Kazia Therapeutics to Present Data Highlighting Synergistic Activity Between Paxalisib and Immunotherapy in Immunotherapy-Resistant Triple Negative Breast Cancer Model at the San Antonio Breast Cancer Symposium

Yahoo FinanceDec 11 21:00

Leptomeningeal Metastases Pipeline Development Research Report 2024, Featuring AstraZeneca, Kazia Therapeutics, and Plus Therapeutics

Yahoo FinanceDec 5 23:38

Kazia Therapeutics | 20-F: FY2024 Annual Report

SECNov 16 05:10 · Announcements

Kazia Therapeutics Secures Nasdaq Compliance

TipRanksNov 12 23:40

Express News | Kazia Therapeutics -Got Letter From Nasdaq Informing Co Has Regained Compliance With Minimum Bid Price Requirement for Continued Listing

BreakingsNov 12 23:09

Express News | Kazia Therapeutics Ltd - Full Data From Paxalisib Arm Expected Later This Year

BreakingsNov 4 20:30